Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI gadolinium diffusion in the inner ear of patients with Ménière's disease
2015-002375-22Phase 4Terminated
- Sponsor
- CHU Grenoble Alpes
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of gadoterate meglumine in Meniere Disease, sponsored by CHU Grenoble Alpes. Started Jun 2015; status: terminated.
02
Drugs
gadoterate meglumine
03
Conditions
Meniere Disease
Beyond the preview
Go deeper on 2015-002375-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002375-22.